Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing Antibody Science

Advancing antibody drugs and biosimilars to address unmet medical needs.

Creating Value for a Healthier Life

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 64
Number Thumbnail Title Author Date Votes Views
64 Prestige Biopharma Enters Strategic MOU with Charles River , a Global Contract Research Organization
김** | 2026.07.02 | Votes 0 | Views 134
김** 2026.07.02 0 134
63 Prestige Biopharma to Present Clinical Development Strategy for Pancreatic Cancer Candidate at ESMO GI 2026
김** | 2026.06.30 | Votes 0 | Views 185
김** 2026.06.30 0 185
62 Prestige Biopharma to Participate in BIO USA 2026, Targeting Global Market Expansion
김** | 2026.06.16 | Votes 0 | Views 380
김** 2026.06.16 0 380
61 Prestige Biopharma IDC Selected for Ministry of Health and Welfare’s Advanced Biopharma Convergence Talent Development Program
김** | 2026.06.08 | Votes 0 | Views 407
김** 2026.06.08 0 407
60 Prestige Biopharma Outlines Phase 2a Clinical Development Roadmap for Pancreatic Cancer Therapy PBP1510
김** | 2026.06.01 | Votes 0 | Views 465
김** 2026.06.01 0 465
59 Prestige Biopharma Expands Global Collaboration Opportunities for Pancreatic Cancer Therapy at ASCO 2026
김** | 2026.05.26 | Votes 0 | Views 445
김** 2026.05.26 0 445
58 Prestige Biopharma IDC Signs Joint Research Agreement for Antibody Therapeutic Development Targeting Cancer Cachexia
김** | 2026.05.19 | Votes 0 | Views 559
김** 2026.05.19 0 559
57 Prestige BioPharma IDC Successfully Attracts Investment for Co-Development Partner
we******** | 2026.05.13 | Votes 0 | Views 499
we******** 2026.05.13 0 499
56 IDC Expands Asset Value to Over 200 Billion KRW… "Accelerating Commercialization on the Back of Financial Stability"
we******** | 2026.05.11 | Votes 0 | Views 608
we******** 2026.05.11 0 608
55 BJFEZ Expands ‘Insight Trip’ Program to High School Students: “Discovering the Future On-Site”
we******** | 2026.04.29 | Votes 0 | Views 512
we******** 2026.04.29 0 512

Read Prestige news >>